Skip to main content
. 2014 Jun 25;15(7):11220–11233. doi: 10.3390/ijms150711220

Figure 4.

Figure 4

Clinical relevance of the REST signature in neuroblastoma patients. Patients in late stage (stage IV) had higher REST scores (ANOVA test p value = 0.0275) than those in early stages. Of note, there were no Stage II patients in this cohort.